SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001698530-24-000027
Filing Date
2024-05-16
Accepted
2024-05-16 16:40:11
Documents
79
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A xcur-20230331.htm   iXBRL 10-Q/A 1016025
2 EX-31.1 exicureexhibit311-33123.htm EX-31.1 7832
3 EX-32.1 exicureexhibit321-33123.htm EX-32.1 7427
  Complete submission text file 0001698530-24-000027.txt   5827898

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20230331.xsd EX-101.SCH 52315
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xcur-20230331_cal.xml EX-101.CAL 57802
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20230331_def.xml EX-101.DEF 215378
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20230331_lab.xml EX-101.LAB 577596
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20230331_pre.xml EX-101.PRE 405109
83 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20230331_htm.xml XML 686395
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-39011 | Film No.: 24956246
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)